Viewing Study NCT03563066

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:20 PM
Ignite Modification Date: 2026-03-13 @ 8:37 PM
Study NCT ID: NCT03563066
Status: COMPLETED
Last Update Posted: 2025-08-22
First Post: 2018-06-08
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Effect of Benralizumab in Atopic Dermatitis
Sponsor: McMaster University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Dermatitis, Atopic View
None Dermatitis View
None Eczema View
None Skin Diseases View
None Skin Diseases, Genetic View
None Genetic Diseases, Inborn View
None Skin Diseases, Eczematous View
None Hypersensitivity View
None Hypersensitivity, Immediate View
None Immune System Diseases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Skin Lesions View
None Benralizumab View
None Eosinophils View
None Intra-dermal challenge View
None Anti-inflammatory agents View
None Physiological Effects of Drugs View